Amid the rising prevalence of cancer worldwide, significant strides have been made in the cancer diagnostics market to improve treatment outcomes and survival rates. According to Roots Analysis, the ...

Should you invest in stocks right now? Some might be hesitant to do so because of the volatility broader equities have faced ...

Dr Joshua Nass, of the Michigan Institute for Neurological Disorders, discussed the 10 most common signs of ailing health ...

There is sufficient blood in stock for those injured in the Uttara plane crash, said Prof Dr Sayedur Rahman, Special ...

Poor-quality or unregulated caviar also carries a risk of heavy metal or pollutant contamination; however, Gentry notes that ...

Johnson & Johnson reported second-quarter results on July 16. Sales of pharmaceuticals have been muted due to a loss of ...

If you're on the hunt for an investment that can provide a steady stream of passive income, look no further than dividend stocks. One that stands out is Energy Transfer ( ET 0.06%), which boasts an ...

--Treatment.com AI Inc. announces that it has granted 799,920 restricted share units and 162,480 stock options to officers, directors, consultants and employees of the Company. FN Media’ s ...

The cash-and-stock deal was originally agreed at the start of this year, and although it's been described as a "merger of equals," the Getty Images name will be retained for the combined entity.

Merus stock is getting serious attention from Wall Street analysts after the biotech company delivered impressive cancer treatment data. The company now holds a consensus “Buy” rating from 16 analysts ...

Trevi Therapeutics (NASDAQ:TRVI) stock jumped about 40% premarket after its mid-stage trial for Haduvio, a potential treatment for chronic coughing, met its main goal. Haduvio, the company's ...

How Freepik Transformed From a Stock Image Platform Into a Generative AI Powerhouse Joaquín Cuenca Abela reveals how Freepik embraced AI and became a creative hub with tools for video, audio, image ...